Cost-effectiveness of symptom monitoring with patient-reported outcomes during routine cancer treatment

The results of this analysis show that for a cost increase of $3360 CAD, the use of a PRO tool for symptom monitoring yields an additional 0.25 QALYs. At a cost per QALY of ∼$13,450, this would be considered good value for money at the typically accepted Canadian standard of $50,000 per QALY.